Journal of Neurology

Article	Citations
The deltoid muscle and the pattern of paresis in ALS	208
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	199
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	138
Tacrolimus-induced Parkinsonism	98
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	92
The DeMyers: Marian (1922–2012) and William (1924–2008)	89
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	88
Richard Caton (1842-1926)	80
Tourette syndrome: effects of acetyl-leucine in two individuals	79
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	78
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	76
Complications of reversible cerebral vasoconstriction syndrome in relation to age	75
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	75
Dizziness and spatial disorientation in patients with transient global amnesia: clinical and vestibular correlates	71
Hashimoto’s encephalopathy with diffuse leukoencephalopathy: serial MRI and gait analysis	70
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis	68
Explaining recovery from coma with multimodal neuroimaging	67
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	66
Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity	64
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	62
Performance of blind source separation in localizing seizure onset from routine scalp-EEG	60
Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers	60
Nomograms integrating cortical morphometric metrics with 3D multi-parametric MRI radiomics for predicting disability progression and cognitive worsening in relapsing–remitting multiple sclerosis: a mu	59
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	58
Perceptual response characterization in acute vestibular implant stimulation	56

Comprehensive effects of Parkinson’s disease multimodal complex treatment (PD-MCT): a two-center prospective trial	56
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	56
Effects of deep brain stimulation on non-motor symptoms in Parkinson’s disease: insights from longitudinal studies using consistent evaluation scales	55
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	54
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism	51
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	51
Prevalence of infratentorial superficial siderosis in a large general population sample from the UK Biobank	50
Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?	50
Prevalence of hereditary transthyretin amyloidosis in CIDP patients with red flags: a multicenter genetic screening and misdiagnosis analysis	50
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	49
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective	49
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension	48
Restless legs syndrome in Parkinson’s disease: epidemiology, pathogenetic overlaps, and clinical management	48
Longitudinal predictors of health-related quality of life in isolated dystonia	48
Recent applications of quantitative electroencephalography in adult intensive care units: a comprehensive review	47
Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis	47
International survey on the implementation of the European and American guidelines on disorders of consciousness	47
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	46
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	46
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies	46
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	45
Disrupted and reorganized connectivity of brain networks in multiple sclerosis: a systematic review and meta-analysis of resting-state functional MRI	45
Neurological manifestation of HEV infection: still a rare disease entity?	45
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study	44
Cross-sectional brain volumetric measures and disability outcomes in relapsing–remitting multiple sclerosis	43
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	42
A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder	42
A decision aid is not the quick fix for improving shared decision-making in advanced Parkinson’s disease: results of a mixed methods feasibility study	42
Dystonia management across Europe within ERN-RND: current state and future challenges	42
A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution	41
Ocrelizumab in early relapsing–remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort	41
Improving conscientiousness through a smartphone app and telecoaching intervention: insights from multiple sclerosis and healthy aging samples	41
Cavernomas: to treat or not to treat?	40
Equity in neuromuscular research: a 20-year analysis of race, ethnicity, sex, and age representation	40
Primary progressive aphasia: six questions in search of an answer	40
Episodic symptoms caused by neurovascular conflict of vagus nerve due to hemilateral anterior inferior cerebellar artery	40
Quantitative brainstem and spinal MRI in amyotrophic lateral sclerosis: implications for predicting noninvasive ventilation needs	40
Patent foramen ovale diagnosis in young stroke patients: analysis of recurrence and mortality	39
Health-related quality of life in Japanese patients with multiple sclerosis	39
The topography of infratentorial lesions in depression and anxiety in multiple sclerosis	38
eHealth tools to assess the neurological function for research, in absence of the neurologist: a systematic review, part II (hardware)	38
Sutton’s law applies to functional neurology	38
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD	38
Distributions and network changes of brain activity in the acute phase of anti-NMDAR encephalitis: a MEG study	38
Laura Forster (1858–1917)	38
A novel prediction score determining individual clinical outcome 3 months after juvenile stroke (PREDICT-score)	37
The intersection of delirium and long-term cognition in older adults: the critical role of delirium prevention	37
Architecture and anatomy of executive processes: evidence from verbal fluency and Trail Making Test in 2009 stroke patients	36
Challenges in multinational rare disease clinical studies during COVID-19: regulatory assessment of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease	36
Cognitive stimulation in Parkinson’s disease with mild cognitive impairment	36

Dysregulation of the molecular clock by blood-borne factors in Alzheimer’s disease patients	36
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules	35
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study	34
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study	34
Encephalitis in HIV-infected adults in the antiretroviral therapy era	34
Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease	34
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial	33
Regional free-water diffusion is more strongly related to neuroinflammation than neurodegeneration	33
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry	33
Is there a spinal tap responder in progressive supranuclear palsy? The first prospective study	33
Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19	32
Management of hypersensitivity in a patient with late-onset Pompe disease experiencing recurrent infusion-related reactions	32
Characterisation of RT-QuIC negative cases from the UK National CJD Research and Surveillance programme	32
Bilateral beaded watershed infarction secondary to acute anemia from gastrointestinal bleeding	32
The Sternbergers: Ludwig (1921–2008) and Nancy (1938–2014)	32
Cost effectiveness of different treatment strategies with natalizumab for pregnant women with multiple sclerosis	32
Evaluating 18F-Florzolotau tau PET for Alzheimer’s disease diagnosis with 18F-Flortaucipir as reference	32
Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study	31
Artificial intelligence in neurology: opportunities, challenges, and policy implications	31
The role of language-related functional brain regions and white matter tracts in network plasticity of post-stroke aphasia	31
Quantification of saccadic fatigability and diagnostic efficacy for myasthenia gravis	31
Non-invasive biomarkers for diagnosis and monitoring of primary mitochondrial diseases	31
The clinical phenotype of psychiatric-onset prodromal dementia with Lewy bodies: a scoping review	31
Machine learning for adaptive deep brain stimulation in Parkinson’s disease: closing the loop	31
Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review	30
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective	30
A multi-domain lifestyle intervention in multiple sclerosis: a longitudinal observational study	30
Audiovisual analysis of the diagnostic video polysomnography in patients with isolated REM sleep behavior disorder	30
Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3	30
Analyzing the relationship between specific brain structural changes and the diffusion tensor image analysis along the perivascular space index in idiopathic normal pressure hydrocephalus	30
Segmental distal amyotrophy and cold paresis due to chronic CSF leak with ventral longitudinal epidural collection: a case report	30
Detection of patent foramen ovale in patients with ischemic stroke on prospective ECG-gated cardiac CT compared to transthoracic echocardiography	30
Estimation of ataxia severity in children with ataxia-telangiectasia using ankle-worn sensors	30
Feasibility, safety and efficacy of multi-dose vagus nerve stimulation in Parkinson’s disease: a double-blind, randomised sham-controlled proof-of-concept study	29
Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report	29
Air pollution, greenspace exposure and risk of Parkinson's disease: a prospective study of 441,462 participants	29
Regional brain atrophy subtypes in spinocerebellar ataxia type 3: links to clinical performance and treatment response	29
Systematic review and evidence gap mapping of biomarkers associated with neurological manifestations in patients with COVID-19	29
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry	29
The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia	29
Endolymphatic space is age-dependent	28
Effects of transcutaneous auricular vagus nerve stimulation on motor and gait performance in Parkinson’s disease: a meta-analysis of randomized controlled trials	28
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors	28
Aphasia as a stroke mimic in older adults: a diagnostic challenge	28
Matched-pair analysis of motor outcomes in adults with spinal muscular atrophy on nusinersen vs. risdiplam	28
Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study	28
Genetic variation of low-to-medium-affinity Fc-gamma receptors in Guillain-Barré syndrome	28
Inflammatory neuropathy with evidence of anti-GQ1b antibodies in angioimmunoblastic T cell lymphoma (AITL): a case report	28
Procedural and Clinical Outcome of Stroke after thrombectomy according to etiology: results from a nationwide registry	28
Left- vs right-sided migraine: a scoping review	28
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology	27
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression	27
Novel biomarkers and neuroimaging techniques in Parkinson’s disease	27
MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions	27
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study	27
Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s	27
Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairment	27
The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review	27
Precision diagnosis and precision treatment for the genetic epilepsies	27
Rate of change in upper and lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis	27
Neurological update: structural and functional imaging in epilepsy surgery	27
The vicious cycle: unraveling the interplay between α-synuclein, mitochondrial dysfunction, and neuroinflammation in Parkinson’s disease	27
Genetic risk factors of Alzheimer’s Disease disrupt resting-state functional connectivity in cognitively intact young individuals	27
Beneficial effect of N-acetyl-DL-leucine on cognitive function, emotional well-being and QoL in a mentally healthy elderly person	27
Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study)	26
Different approaches to test orientation of self in space: comparison of a 2D pen-and-paper test and a 3D real-world pointing task	26
Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study	26
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A	26
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry	26
Diagnosing primary lateral sclerosis: a clinico-pathological study	26
Reassessing the adverse event profiles of levetiracetam and brivaracetam: a systematic review and meta-analysis	25
Modulation of spontaneous motor unit potentials by a new motor cortical magnetic stimulation method in amyotrophic lateral sclerosis	25
Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim	25
Diagnostic accuracy and confounders of vagus nerve ultrasound in amyotrophic lateral sclerosis—a single-center case series and pooled individual patient data meta-analysis	25
Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19	25
The impact of the SARS-CoV-2-pandemic on patients with chronic inflammatory neuropathies: results from the German INHIBIT register	25
Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies	25
Refractory focal epilepsy evolving into a Lennox–Gastaut syndrome-like	25
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision	25
Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy	25

The value of magnetic resonance imaging of the optic nerve for the diagnosis of multiple sclerosis in patients with optic neuritis	25
Correction: Metabolomic profile of cerebrospinal fluid from patients with diffuse gliomas	25
Distal hereditary motor neuronopathy as a new phenotype associated with variants in BAG3	24
Parkinson’s disease with hyposmia and dysautonomia: does it represent a distinct subtype?	24
Comparing caloric and self-experienced dizziness symptoms: diagnostic value and implications in functional dizziness	24
Efficacy and safety of adjunctive perampanel treatment in pediatric patients with epilepsy aged 4–12 years: a real-world study	24
Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study	24
CSF phospho-tau levels at Parkinson’s disease onset predict the risk for development of motor complications	24
Recurrence and long-term outcomes of Tolosa-Hunt syndrome	24
Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum	24
Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease	24
Correlation between cognitive changes and neuroradiological changes over time in multiple sclerosis: a systematic review and meta-analysis	24
Integrating standard and native spaces for radiomics and brain network analysis in Alzheimer’s disease diagnosis and prognosis	24
Accuracy of the central vein sign in diagnosis of multiple sclerosis: a systematic review and meta-analysis	24
Could galcanezumab modulate inflammatory cytokines? A single-centre exploratory study	24
Epileptogenicity of white matter lesions in cerebral small vessel disease: a systematic review and meta-analysis	24
Widespread and progressive brain atrophy is a common feature in patients with mitochondrial disease	24
Frida Kahlo could have had cauda equina syndrome: a case report	23
Specific clinical and radiological characteristics of anti-NMDA receptor autoimmune encephalitis following herpes encephalitis	23
Incidence of cerebral small vessel disease-related MR markers in the Swedish general population ‘Good Aging in Skåne’(GÅS) study	23
Association of rare variants in genes of immune regulation with pediatric autoimmune CNS diseases	23
Exploring the impact of 40 Hz multi-luminaire light exposure in Alzheimer's dementia: insights from a convenient sampling, non-randomized case–control study	23
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications	23
Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies	23
Treatment of functional neurological disorder: an umbrella review of systematic reviews and meta-analyses	23
The correlation between 9-HPT and patient-reported measures of upper limb function in multiple sclerosis: a systematic review and meta-analysis	23
Systematic assessment of square-wave jerks in progressive supranuclear palsy: a video-oculographic study	22
Good vibrations: tactile cueing for freezing of gait in Parkinson’s disease	22
The effects of dopaminergic medication and task load on trembling and akinetic freezing of gait in Parkinson’s disease	22
Overcoming traps and pitfalls leading to misinterpretation of normal EEG variants and variation of the background activity	22
Orthostatic blood pressure trajectories characterize heterogeneous disease progression in Parkinson's disease	22
Fluctuations in serum aquaporin-4 antibody titers: the clinical significance in neuromyelitis optica spectrum disorder	22
Frequency and predictors of poststroke epilepsy after mechanical thrombectomy for large vessel occlusion stroke: results from a multicenter cohort study	22
Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments	22
The impact of spontaneous intracranial hypotension on social life and health-related quality of life	22
Case report: anti-argonaute antibodies in Epstein-Barr virus encephalitis	22
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis	22
Locus coeruleus degeneration and cerebellar gray matter changes in essential tremor	22
Effectiveness of endovascular treatment for in-hospital stroke vs. community-onset stroke: a propensity score-matched analysis	22
Effectiveness and safety of pharmacological prophylaxis for chronic migraine: a systematic review and network meta-analysis	21
Subjective and objective responses to caloric stimulation help separate vestibular migraine from other vestibular disorders	21
Neurogenic cough in CANVAS syndrome: objective cough monitoring reveals a distinctive clinical pattern	21
Effects of motor–cognitive training on dual-task performance in people with Parkinson’s disease: a systematic review and meta-analysis	21
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings	21
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort	21
Late-onset cerebellar ataxia in three European patients with repeat expansions in RFC1 and FGF14: a case series	21
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study	21
The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database study	21
Motor and non-motor outcome in tremor dominant Parkinson’s disease after MR-guided focused ultrasound thalamotomy	21
Natural history of facioscapulohumeral muscular dystrophy evaluated by multiparametric quantitative MRI: a prospective cohort study	21
External sensory cueing on gait in Parkinson’s disease: a systematic review and network meta-analysis	21
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption	21
Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study	21
Hypothalamic atrophy in CANVAS/RFC1	21
Correction: Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study	21
Effectiveness of telemedicine-based rehabilitation after stroke: a systematic review	21
Diagnostic utility of neurofilament markers for MND is limited in restricted disease phenotype and for differentiation from compressive myeloradiculopathies	20
Upper motor neuron-predominant motor neuron disease: a novel immunotherapy-responsive association of GAD65 autoimmunity	20
(William) Ritchie Russell (1903–1980)	20
Leg stereotypy syndrome: phenomenological and quantitative analysis	20
Satralizumab as a treatment for pediatric-onset neuromyelitis optica spectrum disorder with cluster attack: a case report	20
Comparison of clinical features in patients with vestibular migraine and migraine	20
Frataxin analysis using triple quadrupole mass spectrometry: application to a large heterogeneous clinical cohort	20
Pathological findings in autoimmune encephalitis autopsy specimens from cases of suspected prion disease	20
The impact of an MSU service on acute stroke care in a middle-sized city: a simulation-based analysis	20
Louis Jacobsohn-Lask (1863–1940)	20
Acetyl-dl-leucine in cerebellar ataxia ([18F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?	20
A rare case of a wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with cutaneous lupus erythematosus after COVID-19 infection	20
Endovascular thrombectomy with or without intravenous alteplase in acute stroke: a systematic review and meta-analysis of randomized clinical trials	20
Chronic vertigo and central oculomotor dysfunction with evidence of anti-ITPR1 antibodies	20
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study	20
Plasma NfL and GFAP in the preclinical stages of neurodegenerative diseases: insights from the UK Biobank	20
Conjugate torsional pendular nystagmus and palatal tremor after unilateral internuclear ophthalmoplegia	20
Olfactory dysfunction is common in classical infratentorial superficial siderosis of the central nervous system	20
A novel phenotype in an Italian family with a rare progranulin mutation	20
Explaining cognitive function in multiple sclerosis through networks of grey and white matter features: a joint independent component analysis	20
Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy	19
Cognitive impairment associated with cerebellar volume loss in spinocerebellar ataxia type 3	19
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort	19
Motor function in multiple sclerosis assessed by navigated transcranial magnetic stimulation mapping	19
Neurosarcoidosis	19
Movement disorders in autoimmune encephalitis: an update	19
A disproportionality analysis of surgical site infections across multiple sclerosis disease modifying therapies	19
Optic neuritis and MOGAD	19
Risk and sex-specific trends of dementia and stroke in Italy Compared to European and high-income countries and the world: global implications	19
Real-life evaluation of the 2017 McDonald criteria for relapsing–remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis	19
Serum neurofilament light chain associates with symptom burden in Lyme neuroborreliosis patients: a longitudinal cohort study from Norway	19
Early therapy initiation is crucial in chronic inflammatory demyelinating polyneuropathy: prospective multimodal data from the German INHIBIT registry	19
Stroke in adults with primary intracranial tumours	19
Correction to: Outcomes of mechanical thrombectomy in patients with acute ischemic stroke and thrombocytopenia: systematic review and meta-analysis	19
NMOSD typical brain lesions after COVID-19 mRNA vaccination	19
The overlooked side of myasthenia gravis: the non-motor manifestations—a comprehensive review	19
COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore	19
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages	19
Understanding social media: how its popularity could be used to advance medical education in stroke care?	19